↓ Skip to main content

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Overview of attention for article published in Lancet Oncology, February 2017
Altmetric Badge
1674

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 4,989)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
194 news outlets
blogs
4 blogs
policy
1 policy source
twitter
159 tweeters
facebook
8 Facebook pages
googleplus
6 Google+ users

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
163 Mendeley